After decades when menopausal women were steered away from hormone therapy due to breast cancer concerns, new evidence shows it may be right for some.

With Monday's ruling, Addyi becomes the first and only FDA-approved pill for low sexual desire in postmenopausal women-an ...

U.S. health officials are taking the first steps toward removing the long-standing black box warning on estrogen products prescribed to treat menopause symptoms — a move that ...

Experts and organizations say hormone therapy is the most effective way to prevent or minimize uncomfortable side effects of menopause. (Getty Images) Hormone therapy (HT) has been a controversial ...

Despite more than a third of women reporting moderate to severe menopause symptoms in 2021, few sought treatment, according ...

Pregnancy, menopause and hormone therapy may all impact a woman’s lipoprotein(a) level, challenging the mantra of the once-in ...

Cate Hall’s sex drive tanked when she hit 40. After months of trying—and failing—to boost it, she read a pamphlet in a doctor ...

Impulsive, anxious, overheated, scatter-brained, depressed and in pain are just some of the terms that many women use to describe themselves when they reach perimenopause, or the years that ...

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...

Treating risk factors that emerge during midlife can reduce a woman’s chances of developing diabetes, heart disease, and ...

Please provide your email address to receive an email when new articles are posted on . Lopez and colleagues conducted a retrospective cohort study using deidentified data from the Optum Clinformatics ...

HSDD affects 40%-55% of postmenopausal women, often due to hormonal changes, impacting sexual desire and quality of life.